Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

3,664 public trials 791 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT07222566

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, +19 more
Locations
  • Pioneer Research Center Bullhead City, Arizona, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Ironwood Cancer & Research Centers Gilbert, Arizona, United States
  • Ironwood Cancer & Research Centers Glendale, Arizona, United States
View all 413 locations
View Trial Details
Recruiting

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

NCT07286149

Conditions
Lung Diseases, Lung Neoplasm Malignant, Lung Neoplasms, +5 more
Locations
  • Clermont Oncology Center ( Site 0041) Clermont, Florida, United States
  • University of Illinois Hospital & Health Sciences System ( Site 0044) Chicago, Illinois, United States
  • Providence Portland Medical Center ( Site 0043) Portland, Oregon, United States
  • Providence Oncology and Hematology Care Clinic - Westside ( Site 0059) Portland, Oregon, United States
View all 25 locations
View Trial Details
Recruiting

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

NCT07486817

Conditions
Lung Cancer, Non-squamous, Non-small Cell, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Cabrini Health Malvern, Victoria, Australia
  • Fiona Stanley Hospital Murdoch, Western Australia, Australia
  • Guangdong Provincial People's Hospital Guangzhou, China
View all 17 locations
View Trial Details
Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

NCT06758401

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center Fullerton, California, United States
  • St. Jude Heritage Medical Group - Fullerton Plaza Multi-Specialty Clinic (Pulmonary Function Test) Fullerton, California, United States
  • Intermountain Health Cancer Center Lutheran Hospital Golden, Colorado, United States
View all 372 locations
View Trial Details
Recruiting

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

NCT07519655

Conditions
Cutaneous Melanoma, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations
  • Presbyterian/St Lukes Medical Center Denver, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute- Pharmacy Nashville, Tennessee, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

NCT06765109

Conditions
Anaplastic Lymphoma Kinase-positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Hoag Hospital Newport Beach Newport Beach, California, United States
  • University of California, Irvine Health Orange, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 157 locations
View Trial Details

Related conditions